Cardiology

Cardiology CME

Earn Cardiology CME that fits how you practice. ReachMD offers practical, on-demand Cardiology CME/CE designed for cardiologists, fellows, APPs, and the full cardiovascular care team. Explore short, case-based activities and expert discussions across heart failure, interventional cardiology, electrophysiology, imaging, prevention, and more. Use this page to find your next activity fast. Browse learning tracks, jump into trending topics, or choose a series from our partner academies and clinical-practice resources. New activities are added regularly, so you can stay current with emerging evidence and evolving standards of care while earning credit on your schedule.

Start an activity below to earn credit or browse by topic to find the Cardiology CME most relevant to your practice.

769

LikeLikedUnlike

46-60 of 195

Nephrology at the Helm—Advancing Timely CKD Care Through Cross-Specialty Collaboration
CME/CE
Nephrology at the Helm—Advancing Timely CKD Care Through Cross-Specialty Collaboration
- Kelly B. Chen, MSN, AGACNP-BC
- Chuck Vega, MD, FAAFP
- Jay B. Wish, MD
1.00 credits
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
CME/CE
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
- Scott Solomon, MD
0.25 credits
The Fifth Pillar? Closing the Gap in HFrEF
CME/CE
The Fifth Pillar? Closing the Gap in HFrEF
- Carolyn S. P. Lam, MBBS, PhD
- Javed Butler, MD
- Stephen J. Greene, MD, FACC, FHFSA
0.50 credits
The Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum 
CME/CE
The Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum 
- prof. Hiddo Heerspink
- Peter Rossing, MD, DMSc
- Paola Fioretto, MD
0.50 credits
Case-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD
CME/CE
Case-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD
- Rajiv Agarwal, MBBS, MD, FASN, BRCU
- Prof. Dr. Francesc Xavier Cos Claramunt
0.25 credits
Optimizing Outcomes in Patients With oHCM: The Emerging Role of Cardiac Myosin Inhibitors
CME/CE Broadcast Replay
Optimizing Outcomes in Patients With oHCM: The Emerging Role of Cardiac Myosin Inhibitors
- Iacopo Olivotto, MD
- Ahmad Masri, MD, MS
- Pablo Garcia-Pavia, MD, PhD
- Fabian Knebel, MD, PhD
- Caroline Coats, MD
0.50 credits
advertisement
New Insights in the Management of HCM: Exploring the Clinical Spectrum
CME/CE Broadcast Replay
New Insights in the Management of HCM: Exploring the Clinical Spectrum
- Milind Y. Desai, MD, MBA
- Iacopo Olivotto, MD
- Elena Arbelo, MD, PhD
0.50 credits
Crossing Boundaries: CETP Inhibitors and the Next Frontier in Lipid Control
CME/CE Broadcast Replay
Crossing Boundaries: CETP Inhibitors and the Next Frontier in Lipid Control
- Prof. Ulrich Laufs
- Pam R. Taub, MD, FACC, FASPC
- Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
- Christie Ballantyne, MD
0.50 credits
Optimizing Outcomes: Evidence-Based Strategies for Treating Patients With Heart Failure With Mildly Reduced or Preserved Left Ventricular Ejection Fraction
CME/CE
Optimizing Outcomes: Evidence-Based Strategies for Treating Patients With Heart Failure With Mildly Reduced or Preserved Left Ventricular Ejection Fraction
- John McMurray, MD
- Scott Solomon, MD
0.25 credits
MinuteCE®
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
- James Burton, DM, FRCP
- Javed Butler, MD
- Ellie Kelepouris, MD, FACP, FAHA
- Patrick Rossignol, MD, PhD
1.00 credits 9 episodes
The Clinical Weight of TTR: What the Latest Data Reveal
CME/CE
The Clinical Weight of TTR: What the Latest Data Reveal
- Ahmad Masri, MD, MS
- Rola Khedraki, MD, FACC
0.25 credits
Risk Reduction with GLP-1 RAs in Individuals with ASCVD and T2D: 2025 Update
CME/CE
Risk Reduction with GLP-1 RAs in Individuals with ASCVD and T2D: 2025 Update
- Brian P. McDonough, MD, FAAFP
- Silvio Inzucchi, MD
- Darren McGuire, MD, MHSc
0.50 credits
advertisement
Optimize Outcomes in CKD & T2D: A Practical Approach to Initiating and Monitoring Combination ns-MRA & SGLT2i Therapy
CME/CE
Optimize Outcomes in CKD & T2D: A Practical Approach to Initiating and Monitoring Combination ns-MRA & SGLT2i Therapy
- Amy Mottl, MD, MPH
- Prof. Christoph Wanner
0.25 credits
PROMs: Role in Clinical Research and Contributions to PAH Patient Perspectives
MinuteCE®
PROMs: Role in Clinical Research and Contributions to PAH Patient Perspectives
- H. James Ford, MD
1.00 program credits
MinuteCE®
Advancing Patient-Centered Care in PAH
- H. James Ford, MD
- Martha Kingman, DNP, FNP-C
- Jean M. Elwing, MD
- Hilary M. DuBrock, MD
1.00 credits 10 episodes